McKesson Co. (NYSE:MCK) has been assigned an average recommendation of “Hold” from the twenty research firms that are currently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and ten have given a buy rating to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $178.34.
Several research firms have weighed in on MCK. Royal Bank of Canada restated a “hold” rating and set a $170.00 target price on shares of McKesson in a research note on Friday, October 27th. Robert W. Baird restated a “buy” rating and set a $200.00 target price on shares of McKesson in a research note on Wednesday, January 17th. Zacks Investment Research upgraded McKesson from a “hold” rating to a “buy” rating and set a $164.00 target price for the company in a research note on Wednesday, February 14th. Evercore ISI began coverage on McKesson in a research note on Thursday, January 4th. They set an “outperform” rating and a $179.00 target price for the company. Finally, ValuEngine cut McKesson from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st.
Shares of McKesson (NYSE:MCK) traded up $0.74 during mid-day trading on Wednesday, hitting $149.59. The company had a trading volume of 1,139,626 shares, compared to its average volume of 1,920,000. The company has a current ratio of 1.07, a quick ratio of 0.61 and a debt-to-equity ratio of 0.63. The company has a market capitalization of $31,190.00, a PE ratio of 7.19, a P/E/G ratio of 1.37 and a beta of 1.22. McKesson has a fifty-two week low of $133.82 and a fifty-two week high of $178.86.
The company also recently declared a quarterly dividend, which will be paid on Monday, April 2nd. Stockholders of record on Thursday, March 1st will be paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.91%. The ex-dividend date is Wednesday, February 28th. McKesson’s payout ratio is 6.54%.
In other news, Chairman John H. Hammergren sold 65,000 shares of the stock in a transaction on Thursday, December 14th. The stock was sold at an average price of $160.00, for a total value of $10,400,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.20% of the stock is currently owned by corporate insiders.
Institutional investors and hedge funds have recently made changes to their positions in the company. WFG Advisors LP increased its holdings in McKesson by 5.0% in the second quarter. WFG Advisors LP now owns 859 shares of the company’s stock valued at $141,000 after purchasing an additional 41 shares during the period. Hanson & Doremus Investment Management increased its holdings in McKesson by 4.4% in the fourth quarter. Hanson & Doremus Investment Management now owns 7,964 shares of the company’s stock valued at $1,242,000 after purchasing an additional 339 shares during the period. Legacy Capital Partners Inc. increased its holdings in McKesson by 11.5% in the fourth quarter. Legacy Capital Partners Inc. now owns 3,303 shares of the company’s stock valued at $515,000 after purchasing an additional 340 shares during the period. Clarkston Capital Partners LLC increased its holdings in McKesson by 0.7% in the fourth quarter. Clarkston Capital Partners LLC now owns 47,435 shares of the company’s stock valued at $7,397,000 after purchasing an additional 350 shares during the period. Finally, Bristlecone Advisors LLC increased its holdings in McKesson by 3.2% in the third quarter. Bristlecone Advisors LLC now owns 12,101 shares of the company’s stock valued at $1,859,000 after purchasing an additional 375 shares during the period. Institutional investors own 85.47% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “McKesson Co. (MCK) Receives Consensus Recommendation of “Hold” from Analysts” was first published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright laws. The original version of this piece can be accessed at https://stocknewstimes.com/2018/02/21/mckesson-co-mck-receives-consensus-recommendation-of-hold-from-analysts.html.
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.